MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
January 2, 2007
Rich Duprey
Foolish Forecast: Bloody Good Showing for Immucor This blood-testing company's in a growth stage, but is it the right time to buy shares? mark for My Articles similar articles
The Motley Fool
October 4, 2007
Billy Fisher
Immucor Draws First Blood The blood-testing equipment maker sees double-digit growth in both sales and earnings in Q1. mark for My Articles similar articles
The Motley Fool
January 4, 2007
Rich Duprey
Immucor Gets Blood Pumping Blood-testing diagnostic equipment maker beats estimates, but does so at a premium. Investors, take note. mark for My Articles similar articles
The Motley Fool
December 16, 2003
Alyce Lomax
Immucor Bloodied The maker of instruments used by hospitals, labs, and blood banks for blood transfusions sees its shares battered after a second-quarter earnings warning. mark for My Articles similar articles
The Motley Fool
July 13, 2011
Immucor Earnings Preview After beating estimates last quarter by 5 cents, Immucor has set the standard for itself this Monday, July 18. mark for My Articles similar articles
The Motley Fool
March 31, 2008
Rich Duprey
Foolish Forecast: Immucor's Draining Acquisition In advance of earnings, analysts expect blood-tester Immucor to continue to grow sales and profits, in spite of short-term expenses. mark for My Articles similar articles
The Motley Fool
April 5, 2007
Billy Fisher
Another Boost for Immucor Since trading for pennies a share in 2001, shares of Immucor have been on a blistering pace. After the release of the company's third-quarter earnings recently, there's no apparent letup in sight, either. mark for My Articles similar articles
The Motley Fool
January 6, 2011
Seth Jayson
Should You Get Out of Immucor Before Next Quarter? Is Immucor sending any potential warning signs? Take a look at the chart below, which plots revenue growth against AR growth, and DSO. mark for My Articles similar articles
The Motley Fool
January 4, 2007
Rich Duprey
Pressure Rising at Immucor: Fool by Numbers The blood-testing company released second-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
September 24, 2007
Billy Fisher
Getting It Done at Meridian Bioscience Impressive earnings growth and disciplined spending continue to propel this small cap up and up. Investors, take note. mark for My Articles similar articles
The Motley Fool
October 21, 2010
Jordan DiPietro
3 Sinking Stocks for Savvy Investors These stocks have dropped -- maybe there's an opportunity here? mark for My Articles similar articles
The Motley Fool
November 6, 2007
Billy Fisher
5 Health-Care Stocks: Bargain or Bust? They have strong earnings growth and are well off their 52-week highs. Is it time to buy these health care stocks?: WellCare Health Plans... Advanced Medical Optics... NBTY... Sciele Pharma... Immucor... mark for My Articles similar articles